Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model

Goettel, J. A., Kotlarz, D., Emani, R., Canavan, J. B., Konnikova, L., Illig, D., … Snapper, S. B. (2019). Low-Dose Interleukin-2 Ameliorates Colitis in a Preclinical Humanized Mouse Model. CMGH, 8(2), 193–195. https://doi.org/10.1016/j.jcmgh.2019.05.001